FDA Approves AstraZeneca’s Fasenra as Add-On Maintenance Therapy for Children Aged 6 to 11 with Severe Asthma

Posted on by admin

Treatment was initially approved in 2017 for the same indication in children aged 12 and up.

Leave a Reply

Your email address will not be published. Required fields are marked *